BEIJING, CHINA / ACCESS Newswire / May 12, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

MUNICH, DE / ACCESS Newswire / May 12, 2025 / Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announced ...

Q1 revenues increased 412% year over year, driven by AI Nose productsDelivers strong turnaround from gross loss to gross profit in Q1AI Nose gains traction beyond healthcare with strategic ...

Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical ...

Vikas Goyal, MBA, promoted to Partner to lead growth stage investments in late preclinical and clinical stage biotechnology companies. BOSTON, MASSACHUSETTS / ACCESS Newswire / May 12, 2025 / Longwood ...

LUXEMBOURG, LU / ACCESS Newswire / May 12, 2025 / Moolec Science SA (NASDAQ:MLEC; the "Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and ...

Immuno-oncology pioneer partners with AbTherx to build the next generation of immunotherapy drugs MOUNTAIN VIEW, CA / ACCESS Newswire / May 12, 2025 / AbTherx, Inc., a biotechnology company with ...

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat complex, rare diseases while also opening new avenues for protein bioproduction ...

The global drug discovery enzymes market is poised for significant expansion, projected to grow from USD 932.4 million in 2023 to USD 1,751.3 million by 2033, advancing at a compound annual growth ...

The global DNA sequencing services market is poised for significant expansion, with a projected valuation of USD 945.6 million in 2023, expected to surge to USD 2,080.2 million by 2033, according to ...

In recent years, the landscape of dyslexia treatment has evolved dramatically. Once considered a misunderstood learning difficulty, dyslexia is now a central focus in the global movement toward ...

LUND, SE / ACCESS Newswire / May 12, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) is pleased to announce that data from its OPTIMIZE-1 clinical trial will be presented at the 2025 American ...